Ignite Creation Date:
2024-07-17 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470308
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-06-17
Brief Title:
Inappropriate Polypharmacy in Elderly Patients in Primary Care and Deprescribing in Older Patients With Frailty
Sponsor:
University of Crete
Organization:
University of Crete
Study Overview
Official Title:
Inappropriate Polypharmacy in Elderly Patients in Primary Care and Deprescribing in Older Patients With Frailty
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Polypharmacy is a major and growing public health problem occuring within all health care settings worldwide The systematic review of Mansoon et al2017 identified 138 different definitions for polypharmacy from which the most commonly used numerical definition is being this of five or more medicines However numerical definitions do not take into account factors such as comorbidity thus there is a need for a a shift towards the terms appropriate and inappropriate polypharmacy and potentially inappropriate prescribing PIP The prevalence of polypharmacy varies between 10 to as high as around 90 depending on the definition used and the population that is studiedThere is worldwide literature regarding the epidemiology of polypharmacy in the elderly health outcomes and cost The is an abundance of guidelines and tools regarding deprescribing the process of withdrawal of an inappropriate medication supervised by a health care professional with the goal of managing polypharmacy minimizing inappropriate medication and improving outcomes In Greece as pointed out by the SIMPATHY project there is no formal polypharmacy initiative and relative greek literature is scarceThere is no research in Greece regarding the prevalence of PIP among community-dwelling elderly patients as well as there are no studies evaluating the feasibility or effectiveness of deprescribing interventions in the elderly or older patients with frailty
The aim of this thesis is to record in the primary care setting in Crete the underlying barriers and enablers of deprescribing among health care professionals and also to evaluate the clinical outcomes of deprescribing interventions in primary care Additionally the beliefs and attitudes of the patients andor their caregivers towards deprescribing will be recorded
The aim of this thesis is to record in the primary care setting in Crete the underlying barriers and enablers of deprescribing among health care professionals and also to evaluate the clinical outcomes of deprescribing interventions in primary care Additionally the beliefs and attitudes of the patients andor their caregivers towards deprescribing will be recorded
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None